RT Journal Article
SR Electronic
T1 Early Palliative Care Intervention Helps with Decreased Length Of Stay And Cost Cutting In A Safety Net Hospital In The Central Valley Of California
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.05.20169235
DO 10.1101/2020.08.05.20169235
A1 Sodavarapu, Soujanya
A1 Seraj, Siamak M.
A1 Ghotra, Gurinder
A1 Singh, Malkinder
A1 Khosravi, Nasim
A1 Parikh, Kinnari
A1 Jung, Syung Min
YR 2020
UL http://medrxiv.org/content/early/2020/09/15/2020.08.05.20169235.abstract
AB Objective To determine if early palliative care intervention within two days of hospital admission affects the length of stay and cost savings.Methods Using a retrospective chart review, 570 patients who received palliative care consultation were reviewed between 2016 and 2018. 287 patients were seen within two days of days, and the total 355 were seen within three days of admission. Data on length of stay and total charges were analyzed for both groups.Results In the early consult group, both lengths of stay and cost of care in total charges decreased by 64% (p<0.0001) and 58% (p<0.0001), respectively. Multiple linear regressions showed everyone day increase in the date of the consultation is associated with an increase in the length of stay by 1.02 days. (R-squared 0.65, p-value <0.0001, CI 0.95-1.09). The number of palliative care consultations increased by 60% from 2016 to 2017.Conclusion Our study reiterates the importance of a multidisciplinary approach in identifying patients who will benefit from palliative care consultation and addressing goals of care early in their hospital course. As such, our study suggests the importance of emphasizing early palliative care and its potential benefits in public hospitals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding has been obatined for the research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Appropriate IRB approval has been obtained for the study by San Jaoquin General Hospital IRB committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author. SS